Nonalcoholic Steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD), characterized by liver inflammation and damage due to fat accumulation in the liver. Unlike simple fatty liver, NASH can progress to more serious conditions such as fibrosis, cirrhosis, and even liver failure. This chronic liver disease is increasingly recognized as a global health concern, with a rising prevalence linked to the growing incidence of obesity, type 2 diabetes, and metabolic syndrome. Children and adults alike are affected by NASH, with the disease often remaining asymptomatic until it reaches an advanced stage, making early diagnosis and intervention crucia...
